Eastwood Bio-Medical Canada Inc.
Other OTCTotal Valuation
Eastwood Bio-Medical Canada Inc. carries a market capitalization of 47.79M, placing it among publicly traded companies globally. Its enterprise value stands at 66.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 47.79M |
| Enterprise Value | 66.04M |
Share Statistics
Eastwood Bio-Medical Canada Inc. currently has 68.89M shares outstanding.
| Shares Outstanding | 68.89M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 100.97, and the price-to-book ratio stands at -57.37.
| PE Ratio | N/A |
| PS Ratio | 100.97 |
| PB Ratio | -57.37 |
| P/TBV Ratio | -57.85 |
| P/FCF Ratio | -13,980.22 |
| P/OCF Ratio | -13,980.22 |
Enterprise Valuation
| EV / Sales | 101.05 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 3.43 |
Financial Position
Eastwood Bio-Medical Canada Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | -5.70 |
| Debt / EBITDA | -0.19 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -118.88 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
Over the trailing twelve months, Eastwood Bio-Medical Canada Inc. generated 653,544.00 in revenue and converted that into -484,185.00 in net income, yielding earnings per share of -0.01. EBITDA reached -343,696.00, while operating income came in at -450,565.00.
| Revenue | 653,544.00 |
| Gross Profit | 407,046.00 |
| Operating Income | -450,565.00 |
| Pretax Income | -484,186.00 |
| Net Income | -484,185.00 |
| EBITDA | -343,696.00 |
| EBIT | -450,565.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Eastwood Bio-Medical Canada Inc. holds 13,015.00 in cash and equivalents against 64,996.00 in total debt, resulting in a net debt position of 51,981.00. Total book value stands at -1.15M, with working capital of -1.40M providing operational flexibility.
| Cash & Cash Equivalents | 13,015.00 |
| Total Debt | 64,996.00 |
| Net Debt | 51,981.00 |
| Equity (Book Value) | -1.15M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.40M |
Cash Flow
Eastwood Bio-Medical Canada Inc. produced -4,720.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -4,720.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -4,720.00 |
| FCF Per Share | 0.00 |
Margins
Eastwood Bio-Medical Canada Inc. operates with a gross margin of 62.28, reflecting its pricing power and cost economics. The operating margin of -68.94 and net profit margin of -74.09 provide insight into operational efficiency.
| Gross Margin | 62.28 |
| Operating Margin | -68.94 |
| Pretax Margin | -74.09 |
| Profit Margin | -74.09 |
| EBITDA Margin | -52.59 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.00 |
| FCF Yield | -0.01 |
Scores
Eastwood Bio-Medical Canada Inc. posts an Altman Z-Score of -5.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5.34 |